CSL could spend up to $2.2 billion developing a drug to combat rare kidney and liver disease under an exclusive agreement with a Swiss biotech start-up, signing its first major deal since executing ...

CSL already markets a range of kidney disease meds. Australia’s CSL is paying $355 million upfront for the rights to Alentis Therapeutics’ phase 2-stage fibrosis drug. In return for the rights to ...

CSL (CSLLY) agreed to pay Alentis Therapeutics $355 million upfront as part of a global partnership to develop lixudebart, an experimental antibody being studied for serious kidney and liver diseases.

Alentis to receive US$355 million initial payment and up to US$1.2 billion in commercial milestones, with global profits shared MELBOURNE, Australia and BASEL, Switzerland, Oct. 4, 2026 /PRNewswire/ - ...

Oct 5 (Reuters) - Australia's CSL (CSL.AX), opens new tab said on Monday it had entered into an agreement with Swiss drugmaker Alentis Therapeutics to co-develop and co-promote a treatment for ‌rare ...

The shares have already recovered strongly, so I wanted to see whether $250 is realistic. CSL Ltd (ASX: CSL) shares have already recovered strongly from their lows, but they remain well below $250. At ...

After a 1% decline in its revenue in FY26, CSL expects its largest unit, CSL Behring, to achieve mid-single-digit growth in FY27. The projection helped fuel a 15% increase in the share price of the ...

The E46 M3 CSL is arguably one of BMW’s most iconic models. Low production volume and a clear, dedicated effort from the factory to create the most dynamic example of an already incredible car mark ...

Zwischen Badetüchern, Stegen und Sonnenschirmen schafft die Arbeiterkammer Kärnten mit Bücherboot und Bücherinsel besondere Leseräume am Wörthersee. „Ob Entspannung, Abenteuer oder neues Wissen – ...

The College Swimming League (CSL) and ESPN today announced a multi-year media rights agreement that makes ESPN the exclusive home of CSL competition in the United States and Canada. Under the ...

Das Problem trat vermehrt ab April 2026 auf und betrifft eine breite Palette von HP-Geschäftsgeräten: Notebooks, Desktops und Workstations unter Windows 11 in den Versionen 23H2, 24H2 und 25H2. Die ...